DTC Guidances Need Added Focus On Device-Specific Issues – AdvaMed
This article was originally published in The Gray Sheet
Executive Summary
FDA should hold a meeting to discuss device-specific advertising issues so the agency can better address industry concerns when finalizing direct-to-consumer guidances, according to AdvaMed
You may also be interested in...
FDA Withdraws Direct-To-Consumer Ad Guidance, As It Develops Social Media Documents
Agency reps updated stakeholders on guidance development efforts related to advertising and promotion during a Food and Drug Law Institute conference in Washington, D.C.
Device Firms Need More Help Making Direct-To-Consumer “Brief Statements”
Device manufacturers should be given the opportunity to have FDA review their direct-to-consumer ads for restricted devices before they go public, according to AdvaMed
Device Firms Need More Help Making Direct-To-Consumer “Brief Statements”
Device manufacturers should be given the opportunity to have FDA review their direct-to-consumer ads for restricted devices before they go public, according to AdvaMed